跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BAXTER COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP - TGA Drug Approval Details
Approvals
/
TGA
/
BAXTER COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP
Approved
STANDARD
BAXTER COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP
Baxter Healthcare Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
c5b6fbbc5de33681
Company
Baxter Healthcare Pty Ltd
Type
Standard
Approval Details
Approval Id
c5b6fbbc5de33681
Product Name
BAXTER COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP
Artg Id
431652
Artg Name
BAXTER COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP
Sponsor
Baxter Healthcare Pty Ltd
Company Detail Path
/organization/baxter-healthcare-pty-ltd
Artg Date
2023-12-21
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
c5b6fbbc5de33681
Type
Standard
Back to TGA Approvals
